Sarah Milgrom

Sarah Milgrom, MD is an Associate Professor in the Department of Radiation Oncology at the University of Colorado Anschutz Medical Campus School of Medicine. She practices at the University of Colorado Cancer Center and Rocky Mountain Gamma Knife Center, with hospital affiliations at University of Colorado Hospital and Children's Hospital Colorado. Her clinical focus centers on radiation therapy for pediatric and adolescent cancers, particularly hematologic malignancies and lymphomas.

Dr. Milgrom earned her MD from Yale University School of Medicine and completed her undergraduate education with an AB from Princeton University. She completed her internship and residency at Memorial Sloan-Kettering Cancer Center, where she served as Chief Resident in Radiation Oncology.

Her research interests focus on optimizing radiation therapy for pediatric Hodgkin lymphoma, minimizing long-term side effects in childhood cancer survivors, and developing evidence-based guidelines for radiation therapy in hematologic malignancies. She has made significant contributions to understanding the role of radiotherapy in children, adolescents, and young adults with hematologic malignancies, and has been instrumental in developing consensus guidelines for radiation therapy in lymphoma trials through the Children's Oncology Group and National Clinical Trials Network.

Analysis of Dr. Milgrom's recent publications reveals a strong emphasis on pediatric radiation oncology, particularly in Hodgkin lymphoma management. Her work spans clinical trials, consensus guidelines, and investigations into radiation therapy techniques that minimize long-term complications while maintaining efficacy. She has been particularly active in research examining late effects of radiation therapy, including salivary and dental complications, and has contributed to the development of protocols for intensity-modulated radiation therapy in pediatric populations.